Primary glioblastoma thus occurs by a de novo pathway with overexpression of EGFR, whereas secondary glioblastoma develops by a progression pathway in which p53 mutations operate as an initiation step for neoplastic transformations less frequently with EGFR overexpression. The gene discussed is TP53; the disease is glioblastoma.